Cargando…

Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma

Objective: To construct a prognostic evaluation model for clear cell renal cell carcinoma (ccRCC) patients using bioinformatics method and to screen potential drugs for ccRCC. Methods: ccRCC RNA sequencing data, clinical data, and protein expression data were downloaded from the TCGA database. Univa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xuzhan, Sun, Libin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088890/
https://www.ncbi.nlm.nih.gov/pubmed/37056387
http://dx.doi.org/10.7150/jca.81915
_version_ 1785022657404600320
author Ma, Xuzhan
Sun, Libin
author_facet Ma, Xuzhan
Sun, Libin
author_sort Ma, Xuzhan
collection PubMed
description Objective: To construct a prognostic evaluation model for clear cell renal cell carcinoma (ccRCC) patients using bioinformatics method and to screen potential drugs for ccRCC. Methods: ccRCC RNA sequencing data, clinical data, and protein expression data were downloaded from the TCGA database. Univariate Cox and Lasso regression analyses were performed on the combined data to screen out the proteins related to the prognosis, and they were included in a multivariate Cox proportional hazard model. The patients were divided into high and low-risk groups for a survival difference analysis. The predictive power of the model was evaluated on the basis of overall survival, progression-free survival, independent prognostic, clinically relevant receiver operating characteristic (ROC) curve, C-index, principal component, and clinical data statistics analyses. GSEA enrichment and immune function correlation analyses were performed. The samples were divided into different subtypes based on the expression of the risk proteins, and survival analysis of the subtypes was performed. The risk-related protein and RNA sequencing data were analyzed to screen out sensitive drugs with significant differences between the high and low-risk groups. Results: A total of 469 ccRCC-related proteins were screened, of which 13 proteins with independent prognostic significance were screened by univariate Cox, Lasso, and multivariate Cox regression analyses to construct the prognostic model. The sensitivity and accuracy of the model in predicting the survival of patients with ccRCC were high (1 year: 0.811, 3 years: 0.783, 5 years: 0.777). The 13 proteins were closely related to immunity, and the model proteins were different between kidney and tumor tissues according to the HPA database. The samples were divided into three subtypes, and there were obvious clinical characteristics of the three subtypes in the grade and T, N and M stages. According to the IC50 values, CGP-60474, vinorelbine, doxorubicin, etoposide, FTI-277, JQ12, OSU-03012, pyrimethamine, and other drugs were more sensitive in the high-risk group. Conclusions: A prognostic model of protein expression in ccRCC was successfully constructed, which had good predictive ability for the prognosis of ccRCC patients. The ccRCC-related proteins in the model can be used as targets for studying the pathogenesis and targeted therapy.
format Online
Article
Text
id pubmed-10088890
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-100888902023-04-12 Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma Ma, Xuzhan Sun, Libin J Cancer Research Paper Objective: To construct a prognostic evaluation model for clear cell renal cell carcinoma (ccRCC) patients using bioinformatics method and to screen potential drugs for ccRCC. Methods: ccRCC RNA sequencing data, clinical data, and protein expression data were downloaded from the TCGA database. Univariate Cox and Lasso regression analyses were performed on the combined data to screen out the proteins related to the prognosis, and they were included in a multivariate Cox proportional hazard model. The patients were divided into high and low-risk groups for a survival difference analysis. The predictive power of the model was evaluated on the basis of overall survival, progression-free survival, independent prognostic, clinically relevant receiver operating characteristic (ROC) curve, C-index, principal component, and clinical data statistics analyses. GSEA enrichment and immune function correlation analyses were performed. The samples were divided into different subtypes based on the expression of the risk proteins, and survival analysis of the subtypes was performed. The risk-related protein and RNA sequencing data were analyzed to screen out sensitive drugs with significant differences between the high and low-risk groups. Results: A total of 469 ccRCC-related proteins were screened, of which 13 proteins with independent prognostic significance were screened by univariate Cox, Lasso, and multivariate Cox regression analyses to construct the prognostic model. The sensitivity and accuracy of the model in predicting the survival of patients with ccRCC were high (1 year: 0.811, 3 years: 0.783, 5 years: 0.777). The 13 proteins were closely related to immunity, and the model proteins were different between kidney and tumor tissues according to the HPA database. The samples were divided into three subtypes, and there were obvious clinical characteristics of the three subtypes in the grade and T, N and M stages. According to the IC50 values, CGP-60474, vinorelbine, doxorubicin, etoposide, FTI-277, JQ12, OSU-03012, pyrimethamine, and other drugs were more sensitive in the high-risk group. Conclusions: A prognostic model of protein expression in ccRCC was successfully constructed, which had good predictive ability for the prognosis of ccRCC patients. The ccRCC-related proteins in the model can be used as targets for studying the pathogenesis and targeted therapy. Ivyspring International Publisher 2023-03-27 /pmc/articles/PMC10088890/ /pubmed/37056387 http://dx.doi.org/10.7150/jca.81915 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Ma, Xuzhan
Sun, Libin
Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title_full Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title_fullStr Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title_short Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma
title_sort construction and validation of protein expression-related prognostic models in clear cell renal cell carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10088890/
https://www.ncbi.nlm.nih.gov/pubmed/37056387
http://dx.doi.org/10.7150/jca.81915
work_keys_str_mv AT maxuzhan constructionandvalidationofproteinexpressionrelatedprognosticmodelsinclearcellrenalcellcarcinoma
AT sunlibin constructionandvalidationofproteinexpressionrelatedprognosticmodelsinclearcellrenalcellcarcinoma